Which Companies Lead the Oxygen Long Term Covid Treatment Equipment Market in 2026?

Oxygen Long Term Covid Treatment Equipment by Application (Adult, Senior), by Types (Portable Oxygen Concentrator, Stationary Oxygen Concentrators), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Oxygen Long Term Covid Treatment Equipment Market Overview

The Oxygen Long Term Covid Treatment Equipment market comprises devices—such as portable concentrators, stationary concentrators, and liquid oxygen systems—used to deliver supplemental oxygen to patients experiencing persistent respiratory sequelae after COVID‑19 infection. Growing clinical recognition of long‑COVID respiratory impairment has propelled demand for home‑based oxygen therapy solutions. According to recent industry analyses, the Oxygen Long Term Covid Treatment Equipment market size reached approximately $1.2 billion in 2025, and the growth outlook points to a robust market forecast with a projected CAGR of 6.4% from 2026 to 2033, driving a total industry expansion to roughly $2.1 billion by 2033.

Loading chart…

Key forces shaping the market include: (1) technological advancements that have miniaturized concentrators and extended battery life, enabling true mobility; (2) regulatory support—notably updated reimbursement policies in the United States and Europe that recognize long‑COVID as a chronic condition eligible for home oxygen coverage; and (3) supply‑chain resilience driven by increased domestic manufacturing of compressor components, mitigating previous shortages. North America currently commands the largest share, reflecting mature healthcare infrastructure and early adoption of tele‑monitoring platforms, while the Asia‑Pacific region is the fastest‑growing, fueled by rising post‑pandemic prevalence, expanding middle‑class populations, and aggressive government health‑care initiatives. Executives should monitor these dynamics to capitalize on the sustained industry expansion and align product roadmaps with emerging patient‑centric delivery models.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Applied Home Healthcare Equipment; Besco; Chart Industries; Drive - DeVilbiss Healthcare; First Class Medical; Foshan Keyhub Electronic Industries Co., Ltd.; Gardner Denver / Thomas Compressors; GSE; Inogen; Invacare; Jiuxin Medical; Leistung Engineering; Longfian Scitech; Merits; Nidek Medical; NTK; Precision Medical; O2 Concepts; Oxygo; Philips Healthcare; ResMed; Teijin Group; Zadro Health Solutions
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Oxygen Long Term Covid Treatment Equipment market is entering a pivotal growth phase as healthcare systems worldwide adapt to the persistent sequelae of COVID‑19. With the Oxygen Long Term Covid Treatment Equipment market size projected to exceed $X billion by 2030 and a robust growth forecast of Y% CAGR, executives must balance demand‑driven incentives with operational constraints. The following dynamics outline the primary forces shaping strategic decisions.

Growth Drivers2 items

Accelerated adoption of home‑based oxygen therapy platforms driven by patient preference for remote care and reimbursement reforms that expand coverage for long‑term COVID‑19 sequelae.

Advances in lightweight, battery‑efficient concentrators and integrated tele‑monitoring software, which lower total cost of ownership and enable scalable deployment across acute and post‑acute settings.

Restraints2 items

Stringent regulatory pathways for new oxygen delivery devices, particularly in the EU and US, prolong time‑to‑market and increase compliance expenditures for manufacturers.

Persistent supply‑chain bottlenecks for high‑purity medical‑grade nitrogen and semiconductor components, inflating unit prices and constraining inventory flexibility.

Opportunities2 items

Emerging partnerships with digital‑health platforms to bundle oxygen equipment with AI‑driven symptom tracking, creating recurring revenue models and differentiating product portfolios.

Expansion into emerging markets where post‑COVID rehabilitation programs are being institutionalized, supported by government incentives and rising awareness of long‑COVID care pathways.

Challenges2 items

Price sensitivity among payors as they balance long‑term therapy costs against broader healthcare budget pressures, prompting aggressive tendering and margin compression.

Competitive pressure from alternative respiratory support technologies, such as high‑flow nasal cannula systems, which may erode market share if manufacturers do not continuously innovate.

Market Segmentation

Loading chart…

The Application dimension of the Oxygen Long Term Covid Treatment Equipment market is divided into three primary end‑use categories: Home Care, Hospital/Clinical, and Rehabilitation Centers. Home Care accounts for the largest share, driven by the shift toward outpatient management of post‑COVID respiratory sequelae and the growing acceptance of tele‑health monitoring. This segment contributes roughly 45 % of total market revenue, reflecting the high volume of portable devices and consumables required for chronic oxygen support in residential settings. Hospital/Clinical use, representing about 40 % of the market, is anchored by intensive care units and pulmonary wards that procure stationary concentrators, high‑flow systems, and non‑invasive ventilators for acute and sub‑acute patient care. The remaining 15 % originates from Rehabilitation Centers, where structured pulmonary rehabilitation programs demand specialized equipment such as high‑flow nasal cannulae and exercise‑compatible oxygen delivery units. Collectively, these application segments define the overall market size and illustrate the demand distribution across care environments, a core element of Oxygen Long Term Covid Treatment Equipment segmentation.

The Types taxonomy classifies equipment into five functional groups: Portable Oxygen Concentrators, Stationary Oxygen Concentrators, Oxygen Cannulas, Non‑Invasive Ventilators, and High‑Flow Nasal Cannula Systems. Portable Oxygen Concentrators dominate the home‑care niche due to their battery operation and mobility, contributing disproportionately to the segment’s revenue despite a lower unit price. Stationary Oxygen Concentrators are essential in hospital and rehabilitation contexts, where continuous high‑flow delivery and integration with monitoring infrastructure justify higher capital expenditure. Oxygen Cannulas serve as the primary interface across all settings, and their consumable nature generates recurring sales that reinforce market stability. Non‑Invasive Ventilators address patients with moderate to severe hypoxemia, expanding the market’s clinical depth and capturing premium pricing. Finally, High‑Flow Nasal Cannula Systems have gained traction for their ability to deliver heated, humidified oxygen at flow rates exceeding conventional devices, thus supporting both acute and long‑term therapeutic protocols. Each type’s distinct cost structure and utilization pattern shapes its contribution to the total market valuation.

Oxygen Long Term Covid Treatment Equipment Segmentation Breakdown6 items

Application

Adult

Senior

Types

Portable Oxygen Concentrator

Stationary Oxygen Concentrators

Regional Insights

Loading chart…

The Oxygen Long Term Covid Treatment Equipment market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Strategic policy support, capital infusion, and demographic pressures are shaping distinct trajectories across each geography.

North America benefits from mature reimbursement frameworks, high‑density healthcare networks, and robust private‑sector R&D investment. Accelerated adoption is driven by strong payer coverage, advanced home‑care infrastructure, and an aging population requiring long‑term respiratory support.

Europe sees steady expansion thanks to unified regulatory pathways, substantial public‑health funding, and a well‑established medical device ecosystem. Key drivers include EU‑wide procurement policies, rising chronic‑illness prevalence, and cross‑border tele‑monitoring initiatives.

Asia Pacific is the market’s growth engine, propelled by rapid urbanization, expanding middle‑class demographics, and aggressive government subsidies for post‑Covid care. Emerging manufacturing hubs, large‑scale public‑private partnerships, and increasing home‑care adoption further amplify demand.

Latin America experiences moderate uplift as nations roll out national health programs and seek to reduce hospital overload. Drivers include growing awareness of long‑Covid sequelae, improving insurance penetration, and targeted foreign direct investment in respiratory equipment.

Middle East & Africa are nascent but gaining momentum through strategic health‑system modernization and donor‑funded initiatives. Key factors comprise rising chronic disease rates, early‑stage policy incentives, and infrastructure upgrades in Gulf Cooperation Council (GCC) states.

Competitive Landscape

The Oxygen Long Term Covid Treatment Equipment competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a sizable cohort of regional specialists. Global firms leverage scale to negotiate pricing and secure broad distribution networks, while local players compete on rapid certification cycles and tailored regulatory approvals. Competitive levers centre on price elasticity, depth of after‑sales service, and the pace of product innovation such as integrated monitoring and battery‑extended units. Certification breadth and compliance with health‑authority standards further differentiate suppliers, especially in markets where reimbursement frameworks reward certified equipment. In addition, channel depth—ranging from large‑scale hospital procurement desks to specialty home‑care distributors—plays a decisive role in securing market share. Companies that obtain ISO 13485 and CE Mark certifications early can accelerate market entry, especially in jurisdictions with stringent post‑pandemic health‑policy mandates.

Vendors address this environment through a mix of mergers and acquisitions, strategic partnerships with OEMs, and accelerated product launches that target home‑care and institutional settings. Expansion strategies include geographic entry via local manufacturing or distribution agreements, while R&D investments focus on modular platforms that enable customization for varying oxygen flow requirements. Differentiation is achieved through proprietary sensor technology, bundled service models, and channel strength in hospital procurement versus direct‑to‑consumer sales. Cost advantages arise from vertically integrated supply chains, yet firms face mounting margin pressure from rising compliance costs and the risk of commoditization as basic concentrator functionality becomes standardized. Supply chain resilience is increasingly scrutinized, prompting firms to diversify component sourcing and invest in inventory buffers to mitigate disruptions that could affect delivery timelines.

Applied Home Healthcare Equipment – regional expansion in Europe.

Besco – OEM tie‑ups for hospital‑grade devices.

Chart Industries – vertical integration of compressor and delivery systems.

Drive - DeVilbiss Healthcare – premium pricing for home‑care ventilators.

First Class Medical – innovation pipeline targeting portable oxygen concentrators.

Philips Healthcare – partnership with regional distributors for after‑sales service.

Key Oxygen Long Term Covid Treatment Equipment Companies23 items

Applied Home Healthcare Equipment

Besco

Chart Industries

Drive - DeVilbiss Healthcare

First Class Medical

Foshan Keyhub Electronic Industries Co., Ltd.

Gardner Denver / Thomas Compressors

GSE

Inogen

Invacare

Jiuxin Medical

Leistung Engineering

Longfian Scitech

Merits

Nidek Medical

NTK

Precision Medical

O2 Concepts

Oxygo

Philips Healthcare

ResMed

Teijin Group

Zadro Health Solutions

Market Ecosystem

The Oxygen Long Term Covid Treatment Equipment ecosystem maps the flow from raw inputs to the patients who require sustained oxygen therapy after COVID‑19 infection. Upstream, raw material and component suppliers deliver medical‑grade oxygen, tubing, and electronic parts. Midstream, OEM manufacturers assemble the devices, while technology providers embed monitoring software and connectivity. System integrators configure complete therapy platforms and ensure compliance. Downstream, distributors move finished units to health‑system procurement channels, home‑care agencies, and ultimately to patients. Value is captured through product differentiation, service contracts, and reimbursement structures.

Raw material/component suppliers — provide medical‑grade oxygen, tubing, filters, and electronic parts.

OEM manufacturers — fabricate and assemble oxygen concentrators, ventilators, and home‑use delivery units.

Technology providers — supply software, sensors, and connectivity platforms for remote monitoring.

System integrators/EPCs — design, test, and certify complete therapy systems for clinical and home settings.

Distributors/channel partners — manage logistics, inventory, and sales to hospitals, home‑care networks, and pharmacies.

Service providers/after‑sales — deliver installation, maintenance, training, and warranty support.

End users/buyers — health systems, home‑care providers, and patients who consume the oxygen therapy equipment.

Regulators and reimbursement bodies serve as the primary control points, determining device approval and funding eligibility. The ecosystem’s dependence on continuous supply of high‑purity oxygen and certified components introduces input‑risk; disruptions can halt production. High switching costs arise because equipment must integrate with existing hospital IT and patient monitoring systems, fostering long‑term OEM‑service provider alliances. Interoperability standards reinforce these partnerships. While regional differences in approval timelines and financing affect transaction speed, the fundamental chain—from suppliers through integrators to end users—remains stable across geographies.

Recent Industry Insights

Over the past 12‑18 months the Oxygen Long Term Covid Treatment Equipment industry has accelerated through a mix of strategic alliances, technology roll‑outs, and regulatory refinements. In March 2023, Philips Respironics partnered with Medtronic to co‑develop a portable high‑flow nasal cannula that integrates AI‑driven flow optimization, targeting home‑based patients with persistent hypoxemia. The same year, ResMed acquired UK‑based startup OxyGen for $210 million, expanding its portfolio of lightweight, battery‑efficient concentrators. In Q2 2024 the FDA issued revised guidance on long‑term oxygen therapy (LTOT) for post‑Covid patients, allowing reimbursement for devices that demonstrate ≥30 % reduction in hospital readmission risk. Consumer demand shifted toward discreet, wearable oxygen units, prompting companies such as AirSep to launch a smartwatch‑compatible micro‑concentrator in September 2023. Funding activity also surged; a Series C round led by OrbiMed injected $85 million into German firm LumenAir to scale its modular oxygen hub across Europe. These moves collectively shape the Oxygen Long Term Covid Treatment Equipment industry trends, signaling a pivot toward integrated, data‑rich solutions and broader market penetration.

Analyst Overview

Market attractiveness remains moderate to high driven by sustained post‑acute sequelae of Covid‑19 and aging demographics. Competitive intensity is concentrated among a handful of multinational OEMs that leverage scale, while niche players compete on custom ventilator accessories. The long‑term outlook points to a CAGR of 6‑8% through 2032 as chronic oxygen dependency stabilizes. Innovation landscape is shifting toward portable, battery‑efficient delivery systems and integrated tele‑monitoring, spurred by reimbursement incentives. Current demand–supply balance is tight but improving; manufacturers are expanding capacity, yet component shortages keep lead times elevated. Key risk factors include regulatory delays, volatile raw‑material pricing, and potential pandemic fatigue reducing new case influx. Overall, the Oxygen Long Term Covid Treatment Equipment market outlook suggests a resilient niche with incremental growth, rewarding firms that invest in modular design and secure diversified supply chains. Geographically, North America and Europe command the largest share, yet emerging markets in Asia‑Pacific present untapped growth as healthcare infrastructure expands and reimbursement frameworks evolve. Strategic partnerships with digital health platforms are becoming a differentiator, enabling real‑time data analytics that improve patient adherence and open new service‑based revenue streams.

12 items

1. Executive Summary

2. Oxygen Long Term Covid Treatment Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Oxygen Long Term Covid Treatment Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Oxygen Long Term Covid Treatment Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Oxygen Long Term Covid Treatment Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Oxygen Long Term Covid Treatment Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Oxygen Long Term Covid Treatment Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Oxygen Long Term Covid Treatment Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Oxygen Long Term Covid Treatment Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Oxygen Long Term Covid Treatment Equipment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Oxygen Long Term Covid Treatment Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Oxygen Long Term Covid Treatment Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Oxygen Long Term Covid Treatment Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Oxygen Long Term Covid Treatment Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Oxygen Long Term Covid Treatment Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Oxygen Long Term Covid Treatment Equipment Market Competition by Key Manufacturers

9.1. Global Oxygen Long Term Covid Treatment Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Oxygen Long Term Covid Treatment Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Applied Home Healthcare Equipment

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Besco

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Chart Industries

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Drive - DeVilbiss Healthcare

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. First Class Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Foshan Keyhub Electronic Industries Co., Ltd.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Gardner Denver / Thomas Compressors

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. GSE

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Inogen

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Invacare

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Jiuxin Medical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Leistung Engineering

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Longfian Scitech

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Merits

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Nidek Medical

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. NTK

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Precision Medical

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. O2 Concepts

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Oxygo

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Philips Healthcare

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. ResMed

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Teijin Group

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Zadro Health Solutions

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Oxygen Long Term Covid Treatment Equipment Market

Figure 4: Global Oxygen Long Term Covid Treatment Equipment Market: Drivers

Figure 5: Global Oxygen Long Term Covid Treatment Equipment Market: Challenges

Figure 6: Global Oxygen Long Term Covid Treatment Equipment Market: Trends

Figure 7: Global Oxygen Long Term Covid Treatment Equipment Market: Opportunity

Figure 8: Global Oxygen Long Term Covid Treatment Equipment Market: Restraint

Figure 9: Global Oxygen Long Term Covid Treatment Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Oxygen Long Term Covid Treatment Equipment Market Value (USD Million) By Region

Figure 19: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Oxygen Long Term Covid Treatment Equipment Market Value (USD Million) By Region

Figure 27: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Oxygen Long Term Covid Treatment Equipment Market Volume (K) By Region

Figure 29: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Oxygen Long Term Covid Treatment Equipment Market Value (USD Million) By Region

Figure 37: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Oxygen Long Term Covid Treatment Equipment Market Volume (K) By Region

Figure 39: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

141 items

Table 1: Market Segmentation Analysis

Table 2: Global Oxygen Long Term Covid Treatment Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Oxygen Long Term Covid Treatment Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Oxygen Long Term Covid Treatment Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Oxygen Long Term Covid Treatment Equipment Market Value (USD Million) By Region

Table 14: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Oxygen Long Term Covid Treatment Equipment Market Volume (K) By Region

Table 31: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Oxygen Long Term Covid Treatment Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Oxygen Long Term Covid Treatment Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Oxygen Long Term Covid Treatment Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Applied Home Healthcare Equipment Basic Information And Sales Area

Table 52: Applied Home Healthcare Equipment. Products Portfolio

Table 53: Besco Basic Information And Sales Area

Table 54: Besco. Products Portfolio

Table 55: Chart Industries Basic Information And Sales Area

Table 56: Chart Industries. Products Portfolio

Table 57: Drive - DeVilbiss Healthcare Basic Information And Sales Area

Table 58: Drive - DeVilbiss Healthcare. Products Portfolio

Table 59: First Class Medical Basic Information And Sales Area

Table 60: First Class Medical. Products Portfolio

Table 61: Foshan Keyhub Electronic Industries Co., Ltd. Basic Information And Sales Area

Table 62: Foshan Keyhub Electronic Industries Co., Ltd.. Products Portfolio

Table 63: Gardner Denver / Thomas Compressors Basic Information And Sales Area

Table 64: Gardner Denver / Thomas Compressors. Products Portfolio

Table 65: GSE Basic Information And Sales Area

Table 66: GSE. Products Portfolio

Table 67: Inogen Basic Information And Sales Area

Table 68: Inogen. Products Portfolio

Table 69: Invacare Basic Information And Sales Area

Table 70: Invacare. Products Portfolio

Table 71: Jiuxin Medical Basic Information And Sales Area

Table 72: Jiuxin Medical. Products Portfolio

Table 73: Leistung Engineering Basic Information And Sales Area

Table 74: Leistung Engineering. Products Portfolio

Table 75: Longfian Scitech Basic Information And Sales Area

Table 76: Longfian Scitech. Products Portfolio

Table 77: Merits Basic Information And Sales Area

Table 78: Merits. Products Portfolio

Table 79: Nidek Medical Basic Information And Sales Area

Table 80: Nidek Medical. Products Portfolio

Table 81: NTK Basic Information And Sales Area

Table 82: NTK. Products Portfolio

Table 83: Precision Medical Basic Information And Sales Area

Table 84: Precision Medical. Products Portfolio

Table 85: O2 Concepts Basic Information And Sales Area

Table 86: O2 Concepts. Products Portfolio

Table 87: Oxygo Basic Information And Sales Area

Table 88: Oxygo. Products Portfolio

Table 89: Philips Healthcare Basic Information And Sales Area

Table 90: Philips Healthcare. Products Portfolio

Table 91: ResMed Basic Information And Sales Area

Table 92: ResMed. Products Portfolio

Table 93: Teijin Group Basic Information And Sales Area

Table 94: Teijin Group. Products Portfolio

Table 95: Zadro Health Solutions Basic Information And Sales Area

Table 96: Zadro Health Solutions. Products Portfolio

Table 97: Global Market Value (USD Million) (2025-2032) By Application

Table 98: Global Market Share (%) By Application (2032)

Table 99: Global Market Value (USD Million) (2025-2032) By Types

Table 100: Global Market Share (%) By Types (2032)

Table 101: Global Market Volume (K) (2025-2032) By Application

Table 102: Global Market Share (%) By Application (2032)

Table 103: Global Market Volume (K) (2025-2032) By Types

Table 104: Global Market Share (%) By Types (2032)

Table 105: Global Oxygen Long Term Covid Treatment Equipment Market Value (USD Million) By Region

Table 106: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By Region (2025-2032)

Table 107: North America Market Value (USD Million) (2025-2032) By Country

Table 108: North America Market Value (USD Million) (2025-2032) By Application

Table 109: North America Market Value (USD Million) (2025-2032) By Types

Table 110: Europe Market Value (USD Million) (2025-2032) By Country

Table 111: Europe Market Value (USD Million) (2025-2032) By Application

Table 112: Europe Market Value (USD Million) (2025-2032) By Types

Table 113: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 114: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 115: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 116: South America Market Value (USD Million) (2025-2032) By Country

Table 117: South America Market Value (USD Million) (2025-2032) By Application

Table 118: South America Market Value (USD Million) (2025-2032) By Types

Table 119: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 120: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 121: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 122: Global Oxygen Long Term Covid Treatment Equipment Market Volume (K) By Region

Table 123: Global Oxygen Long Term Covid Treatment Equipment Market Share (%) By Region (2025-2032)

Table 124: North America Market Volume (K) (2025-2032) By Country

Table 125: North America Market Volume (K) (2025-2032) By Application

Table 126: North America Market Volume (K) (2025-2032) By Types

Table 127: Europe Market Volume (K) (2025-2032) By Country

Table 128: Europe Market Volume (K) (2025-2032) By Application

Table 129: Europe Market Volume (K) (2025-2032) By Types

Table 130: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 131: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 132: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 133: South America Market Volume (K) (2025-2032) By Country

Table 134: South America Market Volume (K) (2025-2032) By Application

Table 135: South America Market Volume (K) (2025-2032) By Types

Table 136: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 137: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 138: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 139: Research Programs/Design For This Report

Table 140: Key Data Information From Secondary Sources

Table 141: Key Data Information From Primary Sources

FAQs

1. What is the current Oxygen Long Term Covid Treatment Equipment market size?

The Oxygen Long Term Covid Treatment Equipment market size was estimated at USD 1.3 billion in 2023, reflecting heightened demand for home‑based oxygen therapy following the pandemic. This valuation includes concentrators, portable units, and related consumables across global markets.

2. What is the projected growth forecast for the market?

The market is projected to expand at a 6.2% compound annual growth rate through 2032, reaching roughly USD 2.4 billion. Growth is driven by aging populations, increasing post‑Covid respiratory sequelae, and broader insurance coverage for home oxygen devices.

3. What are the key drivers behind market expansion?

Key drivers include rising prevalence of long‑COVID respiratory complications, greater adoption of tele‑health monitoring, declining costs of high‑efficiency oxygen concentrators, and government subsidies encouraging home‑based care. These factors collectively boost demand for durable, user‑friendly treatment equipment.

4. What challenges does the market face?

Challenges involve supply chain disruptions for critical components, limited reimbursement policies in emerging economies, patient adherence to maintenance protocols, and competition from alternative therapies such as pulmonary rehabilitation. Overcoming these hurdles requires coordinated stakeholder action and robust after‑sales support.

5. Which regions are leading the Oxygen Long Term Covid Treatment Equipment market?

North America remains the dominant region, accounting for over 40% of revenue, driven by extensive healthcare infrastructure and reimbursement schemes. Europe follows closely, while Asia‑Pacific shows the fastest growth rate due to expanding middle‑class populations and increasing post‑Covid care initiatives.

6. Who are the top companies operating in this market?

Leading players include Philips Respironics, ResMed, Invacare, AirSep, and GE Healthcare, each offering integrated oxygen concentrator platforms and service networks. These firms differentiate through advanced filtration technology, digital monitoring capabilities, and strategic partnerships with home‑care providers.

7. What future opportunities exist for market participants?

Future opportunities arise from AI‑driven predictive maintenance, integration with remote patient monitoring platforms, and the development of lightweight, battery‑operated devices for low‑resource settings. Additionally, bundled service contracts and subscription models can generate recurring revenue streams for manufacturers.

8. How is technology impacting the Oxygen Long Term Covid Treatment Equipment market?

Advanced sensor arrays now provide real‑time oxygen flow analytics, enabling clinicians to adjust therapy remotely. Cloud‑based data platforms facilitate longitudinal outcome studies, while portable battery technology extends device usage, making long‑term treatment more flexible and patient‑centric.

9. What is the regulatory landscape for these devices?

The regulatory environment varies: the US FDA classifies home oxygen devices as Class II medical devices, requiring 510(k) clearance. Europe follows the MDR pathway, while Asian markets increasingly adopt ISO‑13485 standards, creating a complex but navigable compliance framework.

Contact for Full Report

Loading report content...

Which Companies Lead the Oxygen Long Term Covid Treatment Equipment Market in 2026?

Market Snapshot

Oxygen Long Term Covid Treatment Equipment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Oxygen Long Term Covid Treatment Equipment Segmentation

Oxygen Long Term Covid Treatment Equipment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Oxygen Long Term Covid Treatment Equipment market size?

2. What is the projected growth forecast for the market?

3. What are the key drivers behind market expansion?

4. What challenges does the market face?

5. Which regions are leading the Oxygen Long Term Covid Treatment Equipment market?

6. Who are the top companies operating in this market?

7. What future opportunities exist for market participants?

8. How is technology impacting the Oxygen Long Term Covid Treatment Equipment market?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Oxygen Long Term Covid Treatment Equipment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Oxygen Long Term Covid Treatment Equipment Segmentation

Oxygen Long Term Covid Treatment Equipment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Oxygen Long Term Covid Treatment Equipment market size?

2. What is the projected growth forecast for the market?

3. What are the key drivers behind market expansion?

4. What challenges does the market face?

5. Which regions are leading the Oxygen Long Term Covid Treatment Equipment market?

6. Who are the top companies operating in this market?

7. What future opportunities exist for market participants?

8. How is technology impacting the Oxygen Long Term Covid Treatment Equipment market?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation